Mutations in human immunodeficiency virus type 1 integrase confer resistance to the naphthyridine L-870,810 and cross-resistance to the clinical trial drug GS-9137. (Q38898868)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Mutations in human immunodeficiency virus type 1 integrase confer resistance to the naphthyridine L-870,810 and cross-resistance to the clinical trial drug GS-9137. |
scientific article |
Statements
1 reference
Mutations in human immunodeficiency virus type 1 integrase confer resistance to the naphthyridine L-870,810 and cross-resistance to the clinical trial drug GS-9137. (English)
1 reference
Marc De Maeyer
1 reference
Anneleen Hombrouck
1 reference
Arnout Voet
1 reference
Barbara Van Remoortel
1 reference
Christel Desadeleer
1 reference
Myriam Witvrouw
1 reference
1 reference
Identifiers
1 reference